Cholangiocarcinoma, Cholangitis, Secondary Biliary, COVID-19, Obstructive Jaundice, Pancreas Cancer, SARS-CoV-2
Conditions
Keywords
Obstructive Jaundice, Cholangitis, Pancreas Cancer, COVID-19, SARS-CoV-2, esophagogastroduodenoscopy, Endoscopy, Endoscopic retrograde cholangiopancreatography, Endoscopic ultrasound
Brief summary
In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.
Detailed description
In this study, investigators aim to explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details. evaluate the validity of different GI societies recommendations applied in different GI endoscopy units on the prevention of SARS-CoV-2 nosocomial transmission and the overall impact of this recommendations on the service provided by each GI unit. Target audience: \- Physicians performing advanced gastrointestinal endoscopies in different countries. Objectives: * Primary objective: 1- To explore the status of advanced endoscopy (endoscopic retrograde cholangiopancreatography and endoscopic ultrasound on a global level) in different endoscopy units all over the world, to report the characteristics of patients presented to these units and their procedure details. * Secondary objectives: 1. Effect of COVID-19 precautions on procedure time, procedure success, complications and patient outcomes 2. Effect of COVID-19 on working time and staff number Process: A questionnaire containing advanced endoscopy procedure details in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of advanced endoscopy practice in the studied countries.
Interventions
OTHEREndoscopic management according to standard of care
Endoscopic management according to standard of care by ERCP or EUS according to the indication in each case
Sponsors
Helwan University
National Liver Institute, Egypt
Al-Azhar University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients referred for ERCP or EUS during the study period
Exclusion criteria
* Patients refusing to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Age, gender, nationality | 3 months | Investigators will report the baseline demographic data (age, gender, nationality) of all patients. |
| Indication for procedure, status of SARS-CoV-2 infection | 3 months | Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients. |
| Complete blood count and liver functions tests | 3 months | Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients. |
| procedure related complications | 3 months | Investigators will report the procedure related complications. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Effect of COVID-19 precautions on procedure time | 3 months | Investigators will report wether the precautions lead to increase timing of the procedure |
| Effect of COVID-19 precautions on staff number | 3 months | Investigators will report wether the precautions affected staff number (increased or decreased) |
Countries
Egypt, Germany, Peru, Singapore, United States
Outcome results
None listed